Skip to content

Pågående prosjekter

Informasjon til prosjektledere knyttet til gjennomføring og administrasjon av pågående prosjekter er gitt i menyen nedenfor. Klikk på menyvalg for å gå videre til den aktuelle siden.

Sphenopalatine ganglion block in chronic migraine (MIBLOCK)

Anders Mattias Linde

St. Olavs hospital

18.7

Innovative steroid treatment to reduce asthma development in first-time rhinovirus induced wheezing – INSTAR

Henrik Døllner

St. Olavs hospital

20.0

Immunotherapy for Hematological Malignancies- A Path to Cure

Henrik Hjorth-Hansen

St. Olavs hospital

5.7

Changing the specialist mental health care

Gerd Kvale

Helse Bergen

20.0

Improved prediction of outcome by global strain and mechanical dispersion in patients with myocardial infarction, heart failure and primary prophylactic internal defibrillator

Thor Edvardsen

Oslo universitetssykehus

17.8

BEta-Blocker Treatment after Acute Myocardial Infarction in revascularized patients with preserved left ventricular systolic function

Dan Atar

Oslo universitetssykehus

15.0

Establishment of Molecular profiling for Individual clinical routine Treatment decisions in Early Breast Cancer (EMIT)

Bjørn Naume

Oslo universitetssykehus

20.0

BACK-TO-BASIC – a study of the effect of infliximab on patients with long-term lower back pain and Modic changes

John-Anker Zwart

Oslo universitetssykehus

17.9

Tildeling etter utlysning i 2016:

Prosjekttittel Prosjektleder Koordinerende enhet Mill. kr
Tenecteplase in wake-up ischaemic stroke trial – TWIST Ellisiv B. Mathiesen Universitetssykehuset Nord-Norge 15.5
A Phase 1b/2 clinical trial with Axl kinase inhibitor BGB324 in combination with Dabrafenib/Trametinib or Pembrolizumab in Metastatic Melanoma: Identification of predictive markers of response Oddbjørn Straume Helse Bergen 17.6
Randomized autologous hematopoietic stem cell transplantation vs. Alemtuzumab for patients with relapsing remitting Multiple sclerosis (RAM-MS) Lars Bø Helse Bergen 20.0
PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA-2) Torbjørn Omland Akershus universitetssykehus 20.0
The Nor-DRUM STUDY: assessing the effectiveness of tailoring infliximab treatment by therapeutic drug monitoring Espen Andre Haavardsholm Diakonhjemmet Sykehus AS 12.4
The ASAC-study: Acetylsalisylic Acid as Secondary Prevention in Colorectal Cancer Bjørn Atle Bjørnbeth Oslo universitetssykehus 13.8
The Norwegian Antibiotics for Pneumonia in Children (NAPiC) study Håvard Ove Skjerven Oslo universitetssykehus 19.3
Prosjekttittel Prosjektleder Koordinerende enhet Mill. kr
Tenecteplase in wake-up ischaemic stroke trial – TWIST Ellisiv B. Mathiesen Universitetssykehuset Nord-Norge 15.5
A Phase 1b/2 clinical trial with Axl kinase inhibitor BGB324 in combination with Dabrafenib/Trametinib or Pembrolizumab in Metastatic Melanoma: Identification of predictive markers of response Oddbjørn Straume Helse Bergen 17.6
Randomized autologous hematopoietic stem cell transplantation vs. Alemtuzumab for patients with relapsing remitting Multiple sclerosis (RAM-MS) Lars Bø Helse Bergen 20.0
PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA-2) Torbjørn Omland Akershus universitetssykehus 20.0
The Nor-DRUM STUDY: assessing the effectiveness of tailoring infliximab treatment by therapeutic drug monitoring Espen Andre Haavardsholm Diakonhjemmet Sykehus AS 12.4
The ASAC-study: Acetylsalisylic Acid as Secondary Prevention in Colorectal Cancer Bjørn Atle Bjørnbeth Oslo universitetssykehus 13.8
The Norwegian Antibiotics for Pneumonia in Children (NAPiC) study Håvard Ove Skjerven Oslo universitetssykehus 19.3